Skip to main content

AIM ImmunoTech Inc.

AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000946644

In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.

13F holders, Q1 2026

Institutional positions in AIM ImmunoTech Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
18
+6 vs. Q4 2025
Shares held
175.8K
+87.3K (+98.6%) vs. Q4 2025
Total value
$102.8K
+$2.84K (+2.8%) vs. Q4 2025
New holders
8
2 more added
Sold out
2
1 more reduced

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AIM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 18 institutions
Q1 2021: 38 institutionsQ2 2021: 39 institutionsQ3 2021: 38 institutionsQ4 2021: 43 institutionsQ1 2022: 38 institutionsQ2 2022: 40 institutionsQ3 2022: 38 institutionsQ4 2022: 39 institutionsQ1 2023: 36 institutionsQ2 2023: 34 institutionsQ3 2023: 38 institutionsQ4 2023: 38 institutionsQ1 2024: 33 institutionsQ2 2024: 36 institutionsQ3 2024: 33 institutionsQ4 2024: 35 institutionsQ1 2025: 34 institutionsQ2 2025: 12 institutionsQ3 2025: 15 institutionsQ4 2025: 13 institutionsQ1 2026: 18 institutionsQ2 2026: 18 institutions
Value heldQ1 2026: $102.8K
Q1 2021: $16.8MQ2 2021: $15.5MQ3 2021: $14.7MQ4 2021: $6.86MQ1 2022: $7.12MQ2 2022: $4.68MQ3 2022: $3.36MQ4 2022: $1.67MQ1 2023: $2.05MQ2 2023: $3.01MQ3 2023: $1.97MQ4 2023: $1.83MQ1 2024: $1.93MQ2 2024: $3.15MQ3 2024: $2.43MQ4 2024: $919.3KQ1 2025: $590.0KQ2 2025: $104.8KQ3 2025: $293.9KQ4 2025: $119.8KQ1 2026: $102.8KQ2 2026: $325.6K
Institutions holding AIM and their total value by quarter
QuarterHoldersValue
Q2 202618$325.6K
Q1 202618$102.8K
Q4 202513$119.8K
Q3 202515$293.9K
Q2 202512$104.8K
Q1 202534$590.0K
Q4 202435$919.3K
Q3 202433$2.43M
Q2 202436$3.15M
Q1 202433$1.93M
Q4 202338$1.83M
Q3 202338$1.97M
Q2 202334$3.01M
Q1 202336$2.05M
Q4 202239$1.67M
Q3 202238$3.36M
Q2 202240$4.68M
Q1 202238$7.12M
Q4 202143$6.86M
Q3 202138$14.7M
Q2 202139$15.5M
Q1 202138$16.8M

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding AIM ImmunoTech Inc.; share changes are against Q4 2025.

Institutions holding AIM in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Virtu Financial LLC50,895$30.0K0.00%+50,895New
Geode Capital Management, LLC29,918$17.5K0.00%+12,542+72.2%Added
HRT Financial LP26,032$15.0K0.00%+26,032New
XTX Topco Ltd20,590$12.0K0.00%+20,590New
Jane Street Group, LLC20,047$11.7K0.00%+20,047New
Vanguard Fiduciary Trust Co17,519$10.2K0.00%+17,519New
GWM Advisors LLC5,000$2.92K0.00%+5,000New
Tower Research Capital LLC (TRC)4,668$2.73K0.00%+4,543+3,634.4%Added
Morgan Stanley864$5050.00%00.0%Unchanged
Community Bank, N.A.132$760.00%00.0%Unchanged
Harbour Investments, Inc.32$190.00%+32New
Creative Financial Designs Inc30$180.00%+30New
Advisor Group Holdings, Inc.15$70.00%00.0%Unchanged
Hoey Investments, Inc10$60.00%00.0%Unchanged
UBS Group AG1$10.00%−378−99.7%Reduced
Steward Partners Investment Advisory, LLC2$10.00%00.0%Unchanged
Farther Finance Advisors, LLC1$10.00%00.0%Unchanged
Intesa Sanpaolo Wealth Management1$10.00%00.0%Unchanged
DRW Securities, LLC0$00.00%−69,545−100.0%Sold out
Bank of America Corp0$00.00%−28−100.0%Sold out
Vanguard Group Inc––––Not filed